CE Learning Center
Over the past 2½ years, we have had the extraordinary opportunity to work together with a group of key thought leaders in the area of thrombosis to develop an educational platform to support the needs of clinicians who treat patients either with or at risk for thrombosis. This initiative led to the launch of ThrombosisClinic.com, a complete online thrombosis health care resource offering.
Pharmacy Activities...
Thromboprophylaxis of a Medical Patient With Heart Failure and Renal InsufficiencyGeno J. Merli, MD, reviews the case of an obese 70-year-old woman on bed rest in congestive heart failure with renal insufficiency and anemia. The Use of Heparin as Bridging Therapy When Long-term Oral Anticoagulants Are Interrupted for an Elective Procedure or SurgeryBridging update edited by Dr Alex Spyropoulos and Dr Marc Cohen covering the use of heparin as bridging therapy when long-term oral anticoagulants are interrupted for an elective procedure or surgery, generated from a monograph on antithrombotic therapy in cardiovascular patients. Anticoagulation in Special Populations: Update for PharmacistsThe objective of this Update is to provide pharmacists with current information on dosing of LMWHs in special populations of patients with renal impairment, extremes of body weight, and in pregnancy.
Thromboprophylaxis of a Medical Patient With Heart Failure and Renal InsufficiencyGeno J. Merli, MD, reviews the case of an obese 70-year-old woman on bed rest in congestive heart failure with renal insufficiency and anemia.
The Use of Heparin as Bridging Therapy When Long-term Oral Anticoagulants Are Interrupted for an Elective Procedure or SurgeryBridging update edited by Dr Alex Spyropoulos and Dr Marc Cohen covering the use of heparin as bridging therapy when long-term oral anticoagulants are interrupted for an elective procedure or surgery, generated from a monograph on antithrombotic therapy in cardiovascular patients.
Anticoagulation in Special Populations: Update for PharmacistsThe objective of this Update is to provide pharmacists with current information on dosing of LMWHs in special populations of patients with renal impairment, extremes of body weight, and in pregnancy.
Click here to register
© 2009 Elsevier. All rights reserved. Terms and Conditions | Privacy Policy
© 2009 Elsevier. All rights reserved.